Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA)

Posted by

SELECTBIO

The first essential for a biosimilar is that the sequence is identical to that of the innovator protein. However, bulk recombinant proteins are structurally heterogeneous and control over post-translational modifications presents a formidable challenge.